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Anterograde CTO Techniques
Advances in technique and technology have increased procedural success 
and improved outcomes in chronic total occlusion (CTO) percutaneous 
intervention (PCI).1 These challenging cases are made all the more so by 
the presence of coronary arterial calcification, which is prevalent in CTOs, 
and an independent predictor of procedural success and complications.2–5 
Specific techniques and equipment can be utilised to identify, quantify and 
overcome the procedural obstacles caused by calcium within CTOs. 
Pathophysiology of Calcium in 
Chronic Total Occlusion
Early in the development of a CTO, the plaque is predominantly soft/lipidic, 
with organising thrombus, cholesterol-laden cells, foam cells and loose 
fibrous tissue (Figures 1A and 1B). As the occlusion ages, the composition 
typically becomes more dense, with fibrous tissue and calcific deposits 
(Figure 1C).6 Thus, longer duration CTOs are more heavily calcified than 
those of shorter duration.7
Following coronary artery bypass grafting (CABG), there is accelerated 
progression of atherosclerosis in the native coronary arteries. Possible 
mechanisms for this include blood stasis and low shear stress due to 
competitive flow from the grafts.8 The development of a new CTO in an 
artery post-bypass is common, occurring in 43% of patients within the first 
postoperative year.9 CTOs in post-CABG patients are of higher complexity, 
characterised by more extensive and severe calcification than those in 
non-bypassed vessels. While calcium is most commonly located at the 
proximal cap of a CTO, post-CABG it is frequently present in the adjacent 
proximal and distal vessel, within the CTO segment, and at the distal cap.7 
Unique to the post-CABG circulation, the CTO distal cap is exposed, via 
the bypass graft, to aortic pressure, and thus is more likely to be calcified 
than in non-grafted occlusions exposed to the lower pressures of the 
collateral circulation.7 Interestingly, these vessels are less likely to have 
significant negative remodelling compared with non-calcified non-grafted 
CTO vessels, possibly due to the calcium acting as a scaffold to prevent 
vasoconstriction.7 
Incidence and Epidemiology of Calcium 
in Chronic Total Occlusion
Calcium is prevalent in CTOs. On virtual histology intravascular ultrasound 
(IVUS) analysis, Guo et al. reported that 64% of CTOs contained 
predominantly fibrocalcific plaque.10 In a retrospective study of 1,476 
consecutive CTO PCIs in 1,453 patients in the US, moderate or severe 
calcium, as assessed by coronary angiography, was present in 58% of 
occlusions.11 Patients with these calcified occlusions were older and had 
more comorbidities including diabetes, hypertension, peripheral vascular 
disease, left ventricular systolic dysfunction and renal impairment.11 
Similarly, the PROGRESS registry, Japanese Multicentre registry and a 
substudy of patients in the Japanese registry undergoing retrograde CTO 
PCI reported 57–59% of CTOs had angiographically moderate or severe 
calcification.2,3,12 
Success and Safety in Calcific 
Chronic Total Occlusion
The presence of significant calcification within a CTO has repeatedly been 
shown to be an independent predictor of PCI success and complications, 
and thus calcium is a key component of the CTO complexity scores.2,4,5 
Other adverse anatomical characteristics often coexist, with calcific 
occlusions more likely to be longer, tortuous and to have an ambiguous 
proximal cap.11
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In a subset of patients from the PROGRESS registry in whom initial CTO 
PCI was unsuccessful and who underwent subintimal plaque modification 
(or a ‘modification procedure’), the prevalence of moderate or severe 
calcification was 73%.13 In a Japanese cohort of patients who underwent 
CTCA prior to attempted CTO PCI, 50% of those for whom the attempt was 
unsuccessful had severe calcification identified on CTCA, compared with 
16% of those for whom the procedure was successful.14 When CTO PCI 
was successful in these cases, severe calcification was associated with 
higher rates of restenosis and re-occlusion.
The presence of significant calcification hinders the wire-based strategies 
for crossing an occlusion, with dissection and re-entry techniques often 
necessary.11 In a Japanese study of antegrade wiring, calcification of the 
CTO was found to be the most powerful predictor of procedural failure, 
with an odds ratio of 2.5.15 In addition, moderate or severe calcification 
is associated with longer procedure duration, higher radiation doses, 
larger contrast volumes and a higher incidence of major adverse cardiac 
events (3.7% versus 1.8%) compared with mild or non-calcified CTOs. The 
most frequent complication is perforation with tamponade due to the 
requirement for aggressive calcium modifications techniques.11
Imaging of Coronary Calcium in 
Chronic Total Occlusion
Coronary angiography has a high specificity, but low sensitivity, for 
detecting calcium, and does not provide information about its morphology 
or distribution within the plaque and vessel wall.16 CT coronary 
angiography (CTCA) has higher sensitivity and specificity than coronary 
angiography for detecting, quantifying and assessing the distribution of 
calcium, in addition to providing a more accurate measure of occlusion 
length (Figure 2). While the use of CTCA for procedural planning has been 
associated with improved CTO PCI success rates, an occlusion length >15 
mm and calcification involving >50% of the vessel wall on cross-sectional 
imaging are independent predictors of procedural failure.17–19 
Intracoronary imaging is an essential tool for calcium assessment during 
CTO PCI. With the desire to avoid extending or expanding extra-plaque 
tracks through the subintimal space (SIS) by injecting contrast as required 
for optical coherence tomography, IVUS is usually preferred. In calcified 
CTOs, IVUS is useful at several stages during the PCI procedure. It can 
be used to determine the location and the degree of calcification of the 
proximal cap (Figure 3), when this is angiographically ambiguous. After 
crossing an occlusion, IVUS can be used to assess the morphology 
and distribution of calcium, to determine the optimal mode of calcium 
modification, and then to confirm adequate modification prior to stent 
implantation. Finally, it can be used for stent optimisation and to measure 
stent expansion.20 Following dissection and re-entry with extra-plaque 
stenting, eccentric stent expansion is common due to the displacement 
of calcific plaque within the vessel structure. In these cases, a pragmatic 
approach should be adopted as to what constitutes an acceptable 
stent result, as overzealous post-dilatation has the potential to cause 
perforation. As in non-CTO PCI, the absolute stent expansion, quantified 
as minimum stent area is the most important predictor of long-term stent 
patency.20
Procedural Challenges in Calcific Chronic 
Total Occlusion Percutaneous Intervention
Lesion Crossing
A procedural set-up with large-calibre supportive guide catheters, a guide 
extension or an anchor balloon is particularly important when treating 
calcified CTOs. 
Figure 1: Chronic Total Occlusion Histology 
A: Chronic total occlusion with organising thrombus; B: Proteoglycan-rich chronic total occlusion; C: Calcified chronic total occlusion. Source: Sakakura et al.7 Reproduced with permission from Oxford 
University Press.
Figure 2: CT Coronary Angiography of 
Calcific Chronic Total Occlusion
CT coronary angiogram demonstrating severe calcification of the proximal and distal caps. 
Source: Spratt et al.37 Reproduced with permission from Optima Education.
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Calcium is most commonly located at the proximal cap, resulting in difficulty 
with wire and microcatheter crossing. Low or medium penetration force 
wires are unlikely to cross the cap and may deflect into the SIS. If an 
antegrade wiring strategy is intended, escalation to a high penetration 
force wire will be required to cross the cap. After the most resistant 
segment has been negotiated, de-escalation to a lower penetration force 
wire is recommended to reduce the risk of wire exit. When there is also 
calcium within the occlusive segment or at the distal cap, further wire 
escalation and de-escalation may be required. 
Coil-based and penetrative microcatheters can facilitate crossing of 
calcific occlusions. Coil-based microcatheters, such as the Corsair (Asahi 
Intecc), Mamba (Boston Scientific) and Turnpike Spiral (Teleflex) have 
internal and/or external coils that allow torque to be applied, to assist 
propagation through calcific or tortuous segments. The Turnpike Spiral 
has the addition of distal external threads, which grip resistant plaque to 
aid crossing, while the Turnpike Gold (Teleflex) has a metallic threaded tip 
designed to engage and penetrate the proximal cap or calcific plaque. 
Caution should be taken in long segments of severe calcific disease 
where the spiral thread or gold metallic tip have the potential to lock into 
the lesion, making them difficult to remove. The Tornus (Asahi Intecc) is an 
alternative stiffer metallic catheter with exposed wrapped wires, which is 
torqued with anti-clockwise rotation.
Intentional balloon rupture, balloon-assisted microdissection or 
‘grenadoplasty’, can be useful to facilitate delivery of equipment through 
the proximal cap or beyond a calcified segment. A small balloon is 
engaged into the plaque and inflated to high pressure to cause balloon 
rupture, resulting in hydraulic disruption and weakening of the plaque. 
When a wiring strategy with intraplaque crossing is not feasible due to 
calcification, dissection techniques can be employed by deliberately 
entering and traversing the SIS, going extraplaque around the calcific 
occlusion and re-entering the lumen beyond the distal cap. Entry into the 
SIS can occur while attempting to penetrate the proximal cap or by using 
specific techniques (e.g. scratch and go, balloon-assisted subintimal 
entry, power knuckle, contrast-induced hydraulic dissection; Figure 4).21 
Antegrade dissection re-entry is usually performed using the CrossBoss/
Stingray system (Boston Scientific). 
The delivery of equipment and re-entry into the distal lumen can be 
difficult in the presence of calcium, but can be facilitated by the support 
of a guide extension and high penetration force wires. In retrograde 
dissection re-entry, knuckle wires are used to track through the SIS in 
both an antegrade and retrograde manner, until they become overlapped. 
The two extraplaque tracks are then connected by performing balloon 
dilatation to expand the antegrade SIS, allowing passage of a retrograde 
wire into the antegrade guide extension or catheter. 
Plaque Modification
Adequate lesion preparation and calcium modification is essential prior 
to stent implantation to prevent stent underexpansion, the strongest 
predictor of early stent thrombosis and restenosis.22,23 This is particularly 
important in CTO PCI, with longer stented segments increasing the 
risk of restenosis, and with subintimal stenting following dissection 
re-entry techniques. Where possible, IVUS should be used to assess 
calcium modification prior to stenting, and to confirm adequate stent 
expansion.
Pre-dilatation is routinely performed with non-compliant balloons. When 
this is inadequate, an ultra-high-pressure balloon (SIS Medical), cutting 
balloon with longitudinal atherotomes or scoring balloons with an external 
element can facilitate fracturing and disruption of the calcific plaque.24 
While these modifying balloons have been used both intraplaque 
and extraplaque during CTO PCI, it is anticipated that there will be an 
associated increased risk of perforation. 
Figure 3: Calcific Proximal Cap on Intravascular Ultrasound 
Intravascular ultrasound demonstrating a calcific proximal cap (circled). Source: Spratt et al.37 Reproduced with permission from Optima Education. IVUS = intravascular ultrasound. IVUS demonstrating 
a calcific proximal cap.
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The intravascular lithotripsy balloon (Shockwave Medical) delivers sonic 
pressure waves to selectively fracture calcium deep into the vessel wall 
and improve compliance prior to stent implantation.25 While it has been 
demonstrated to be safe and effective in non-occlusive calcific disease, 
to date there is one case series and several case reports of its use during 
CTO PCI, both intraplaque and extraplaque following CTO crossing, 
for in-stent occlusion, to facilitate connection between the antegrade 
and retrograde SIS during retrograde dissection re-entry, and during 
modification procedures.26–30 
In up to 7% of CTOs, failure to cross with a balloon occurs after successful 
guidewire crossing.31,32 In such balloon uncrossable lesions, when there 
is inadequate dilatation with modifying balloons, or when treating a long 
segment of severe calcium, rotational atherectomy (RA) may be indicated. 
With a microcatheter across the occlusion, this can be used to exchange 
for the RotaWire. RA has been reported in case series to be safe and 
effective during CTO PCI, with the use of a small burr advised to reduce 
the risk of perforation.32–35 Occasionally, if other techniques for proximal 
cap crossing fail, RA can be used for cap modification. In this scenario, the 
RotaWire is advanced as far as possible beyond the cap into the occlusion 
or SIS, and a focused pecking motion of the burr is used.
RA use in CTO PCI is uncommon, reported in approximately 3% of 
cases.33,35 Patients requiring RA tend to be older, with a higher prevalence 
of diabetes, left ventricular dysfunction and previous CABG. In the 
majority of reported cases, the CTO was crossed by antegrade wiring and 
RA performed intraplaque, with the indication equally divided between 
failure to cross with a balloon or inadequate balloon expansion. In a 
smaller proportion of cases (20–30%), RA was used safely following 
dissection and re-entry techniques.31,33,35 Cases requiring RA had similar or 
slightly lower rates of technical success (77–90% versus 85–89% in non-
RA cases). Slow/no reflow has been reported in 17%, while perforation 
rates vary – tamponade requiring pericardiocentesis occurred in 2.6% of 
RA cases in the substudy of the PROGRESS registry, but did not occur in 
any RA cases in other, smaller case series.32,33,35
While orbital atherectomy has some potential advantages in non-occlusive 
disease, the location of the ablative crown 6.5 mm proximal to the tip can 
be a disadvantage in CTO PCI, particularly in balloon uncrossable lesions. 
Very few cases have been reported. In the PROGRESS substudy, of 3,607 
CTO PCI cases, RA was used in 105, orbital atherectomy in eight cases 
and both were used in four cases.35
Excimer laser coronary atherectomy generates vapour bubbles to cause 
the molecular breakdown of tissue. It can be useful to treat uncrossable 
proximal caps or occlusive segments, balloon undilatable lesions and 
occlusive in-stent restenosis. It is less available and used less frequently 
than RA or orbital atherectomy. In a cohort of 18 cases in which excimer 
laser coronary atherectomy was used alone or in combination with RA 
during CTO PCI (all of which were antegrade wire escalation), procedure 
success was achieved in 89%, with no perforations or other laser-related 
complications.36 It is anticipated that the use of ECLA extraplaque would 
carry a prohibitive risk of causing perforation of the adventitia. 
Conclusion
Calcification in CTOs is common and presents additional challenges 
during revascularisation of these complex coronary lesions. The presence 
of calcium predicts lower procedural success rates and a higher risk of 
complications. Pre-procedural CTCA and intravascular imaging are useful 
tools to understand the distribution, morphology and severity of calcium. 
Specialised guidewires and microcatheters, as well as penetration, SIS 
entry and luminal re-entry techniques, are required to cross calcific CTOs. 
While the use of each of the balloon-based and atherectomy devices 
have been reported during CTO PCI, there is limited experience, and 
some remaining concerns regarding safety and efficacy when used 
extraplaque. 
Figure 4: Balloon-assisted Subintimal Entry 
+
BASE technique
1. Balloon inflated in proximal vessel (close to CTO)  creates intimal
disruption facilitating access into the subintimal space
2. Microcatheter is positioned proximal to the area of disruption
and a soft polymer with an umbrella-shaped tip is advanced 
into the subintimal plane
3. Inflating a co-axial anchor balloon traps the microcatheter providing 
additional support to advance the knuckle past the proximal cap
BASE + power knuckle
Balloon-assisted subintimal entry technique. BASE = balloon-assisted subintimal entry; CTO = chronic total occlusion. Source: Spratt et al.37 Reproduced with permission from Optima Education.
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